Exec Chat: Kees Wesdorp Leads Philips' Advancement Of Precision Diagnosis During COVID-19
Kees Wesdorp, the leader of Philips' Precision Diagnosis business cluster told Medtech Insight how the division is delivering on digital solutions, beyond acute care, to drive a response to the COVID-19 pandemic
You may also be interested in...
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.